Atlas Trials

Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC)

Clinical trial NCT05543304 · UNKNOWN

Trial details

NCT number
NCT05543304
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma Non-resectableEffect of Drug
Start date
2018-12-01
Primary completion
2023-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.